Pathogenic mechanisms of IgE-mediated inflammation in self-destructive autoimmune responses

Abstract

Autoantibodies of the IgG subclass are pathogenic in a number of autoimmune disorders such as systemic lupus erythomatosus. The presence of circulating IgE autoantibodies in autoimmune patients has also been known for almost 40 years. Despite their role in allergies, IgE autoantibodies are not associated with a higher rate of atopy in these patients. However, recently they have been recognized as active drivers of autoimmunity through mechanisms involving the secretion of Type I interferons by plasmacytoid dendritic cells (pDC), the recruitment of basophils to lymph nodes, and the activation of adaptive immune responses through B and T cells. Here, we will review the formation, prevalence, affinity, and roles of the IgE autoantibodies that have been described in autoimmunity. We also present novel evidence supporting that triggering of IgE receptors in pDC induces LC3-associated phagocytosis, a cellular process also known as LAP that is associated with interferon responses. The activation of pDC with immune complexes formed by DNA-specific IgE antibodies also induce potent B-cell differentiation and plasma cell formation, which further define IgE’s role in autoimmune humoral responses.

• Atopic dermatitis
• autoimmunity
• B cells
• basophil
• class switch recombination
• chronic spontaneous urticaria
• IgE
• interferon
• pemphigus bullous
• plasmacytoid dendritic cells
• systemic lupus erythematosus

Acknowledgements

The authors would like to thank Dr. Gary Sims for critical reading of the manuscript.

Declaration of interest

RE, JLK, SKP, JMR, RK, MAS are full-time MedImmune employees and shareholders of MedImmune/AstraZeneca.